Safety of and Immune Response to a DNA HIV Vaccine (VRC-HIVDNA009-00-VP) in HIV Infected Individuals With Acute HIV Infection
Immune Response to a Therapeutic HIV Vaccine Followed by Treatment Interruption in Patients With Acute or Recent HIV Infection
Therapeutic Vaccination Followed by Treatment Interruption in HIV Infected Patients
Phase I Study of HIV 1 Antigen Expanded Specific T Cell Therapy
A Phase I/II Study to Evaluate the Immunologic Response and Virologic Impact of AGS-004
† Study has passed its completion date and status has not been verified in more than two years.